Optic nerve atrophy is a disorder characterized by varying degrees of destructive changes in the nerve fibers responsible for transmitting signals from the retina to the brain. As a result, the patient experiences reduced visual acuity or complete loss of vision. Effective therapy for this condition requires a high level of qualification and experience from doctors, as well as the availability of modern medical equipment, which explains the frequent visits of patients with such problems to Israeli medical centers. Treatment of optic nerve atrophy in Israel follows an individualized scheme, including progressive medical and surgical methods. Timely therapy in more than 90% of cases significantly alleviates painful symptoms and improves prognosis.
To develop an effective therapeutic program, accurate diagnosis is necessary to determine the factor that caused the development of the pathology. Often, patients from the former CIS countries turn to Israeli clinics, where they could not receive quality assistance for a long time at home. This is usually due to incorrect identification of the initial cause of the atrophy, caused by the outdated material and technical base of medical centers. In Israeli clinics, it is possible to accurately determine the source of the pathology, establish its signs, and select effective therapy methods within a few days, as confirmed by patient reviews. An advantage of receiving treatment in this country is also the reasonable cost of services, which is significantly lower than in other countries that are popular among medical tourists.
Treatment Methods for the Pathology
The development of optic nerve atrophy can be caused by various factors, including:
- ophthalmological disorders (glaucoma, retinal pathologies, tumors of various types);
- central nervous system pathologies (tumors, multiple sclerosis, infectious diseases, traumatic brain injuries);
- bacterial and viral diseases (syphilis, measles, herpes, and others);
- hypertension;
- diabetes;
- intoxications;
- congenital pathologies.
The main symptom is a decrease in visual acuity that cannot be corrected with glasses. About a quarter of patients experience progression of the pathology, leading to complete blindness in a relatively short time. In cases of incomplete atrophy, the patient may lose peripheral vision, and there may be development of